X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (55) 55
humans (44) 44
female (42) 42
endocrinology & metabolism (40) 40
male (39) 39
middle aged (37) 37
adult (34) 34
aged (23) 23
diagnosis (18) 18
tumors (17) 17
young adult (16) 16
abridged index medicus (15) 15
adolescent (13) 13
retrospective studies (13) 13
cancer (12) 12
paraganglioma (12) 12
patients (11) 11
pheochromocytoma (11) 11
pituitary (11) 11
prognosis (11) 11
treatment outcome (11) 11
management (10) 10
surgery (10) 10
aged, 80 and over (9) 9
oncology (9) 9
adrenocorticotropic hormone (8) 8
glucocorticoids (8) 8
nervous system diseases (8) 8
survival (8) 8
carcinoma (7) 7
cross-sectional studies (7) 7
mortality (7) 7
mutation (7) 7
prospective studies (7) 7
adrenal cortex neoplasms - mortality (6) 6
adrenocortical carcinoma - drug therapy (6) 6
analysis (6) 6
cohort studies (6) 6
disease-free survival (6) 6
expression (6) 6
metabolism (6) 6
mitotane (6) 6
survival analysis (6) 6
adenoma (5) 5
adenomas (5) 5
adrenal cortex neoplasms - drug therapy (5) 5
adrenal cortex neoplasms - pathology (5) 5
adrenal gland neoplasms - diagnosis (5) 5
adrenocortical carcinoma - mortality (5) 5
adrenocortical carcinoma - pathology (5) 5
adrenocortical carcinoma - surgery (5) 5
age (5) 5
chemotherapy (5) 5
cushing syndrome - diagnosis (5) 5
cushings-syndrome (5) 5
diabetes (5) 5
endocrinology (5) 5
hydrocortisone (5) 5
immunohistochemistry (5) 5
metastasis (5) 5
phase-ii (5) 5
secretion (5) 5
adrenal cortex neoplasms - diagnosis (4) 4
adrenal cortex neoplasms - genetics (4) 4
adrenal cortex neoplasms - surgery (4) 4
adrenalectomy (4) 4
article (4) 4
catecholamines (4) 4
cushing's disease (4) 4
follow-up studies (4) 4
genetic aspects (4) 4
germany (4) 4
hydrocortisone - blood (4) 4
hypercortisolism (4) 4
medical prognosis (4) 4
metastases (4) 4
morbidity (4) 4
pheochromocytoma - blood (4) 4
pheochromocytoma - diagnosis (4) 4
proteins (4) 4
registries (4) 4
remission (4) 4
sensitivity and specificity (4) 4
therapy (4) 4
ubiquitin (4) 4
urine (4) 4
activation (3) 3
adenoma - metabolism (3) 3
adjuvant mitotane (3) 3
adrenal cortex neoplasms - metabolism (3) 3
adrenal cortex neoplasms - therapy (3) 3
adrenal gland neoplasms - blood (3) 3
adrenal gland neoplasms - epidemiology (3) 3
adrenal glands (3) 3
adrenocortical carcinoma - diagnosis (3) 3
adrenocortical carcinoma - genetics (3) 3
adrenocortical carcinoma - therapy (3) 3
aldosterone (3) 3
animals (3) 3
biochemical-diagnosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2019, Volume 104, Issue 7, pp. 2985 - 2993
Context: Unilateral adrenalectomy has been proposed in selected patients with primary bilateral macronodular adrenocortical hyperplasia (PBMAH), but its... 
ARMC5 MUTATIONS | DIAGNOSIS | CUSHINGS-SYNDROME | QUALITY-OF-LIFE | ENDOCRINOLOGY & METABOLISM | Adrenalectomy | Nervous system diseases | Adrenocorticotropic hormone | Adrenal glands | Pituitary | Hyperplasia | Surgery | Remission | Adenoma | Hydrocortisone | Patients
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 06/2015, Volume 140, Issue 12, pp. 874 - 877
Zusammenfassung Das endogene Cushing-Syndrom ist eine seltene und potentiell verheerend verlaufende Erkrankung, welche durch inadäquat hohe... 
Klinischer Fortschritt | hypercortisolism | cortisol | treatment | subclinical | genetics | ACTH | mortality | medication | glucocorticoids
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 02/2019, Volume 180, Issue 2, pp. 117 - 125
Objective: Current workup for the pre-operative distinction between frequent adrenocortical adenomas (ACAs) and rare but aggressive adrenocortical carcinomas... 
SPECTROMETRY ANALYSIS | P450 OXIDOREDUCTASE | 21-HYDROXYLASE | MANAGEMENT | URINE | ENDOCRINOLOGY & METABOLISM | CONGENITAL ADRENAL-HYPERPLASIA | EXCRETION | MS/MS | MASS-SPECTROMETRY | ADENOMAS | Carcinoma | Mass spectroscopy | Liquid chromatography | Malignancy | Males | Estradiol | Chromatography | Learning algorithms | Fish | Scientific imaging | Progesterone | Diagnosis | Mass spectrometry | Steroid hormones | Tumors
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 11/2017, Volume 102, Issue 11, pp. 4323 - 4332
Journal Article
Cancers, ISSN 2072-6694, 11/2019, Volume 11, Issue 11, p. 1761
Cushing’s disease (CD) is a rare condition caused by adrenocorticotropic hormone (ACTH)-producing adenomas of the pituitary, which lead to hypercortisolism... 
somatic mutations | deubiquitinases | pathogenesis | cushing’s disease
Journal Article
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 01/2015, Volume 82, Issue 1, pp. 84 - 90
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 09/2019, Volume 104, Issue 9, pp. 3812 - 3820
Abstract Context Cross-sectional imaging with CT or MRI is regarded as a first-choice modality for tumor localization in patients with pheochromocytoma and... 
Pheochromocytoma | Magnetic resonance imaging | Computed tomography | Decision making | Paraganglioma | Scintigraphy | Metastasis | Diagnosis | Localization | Patients | Metastases
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, p. e105855
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 02/2019, Volume 26, Issue 2, pp. 531 - 538
In the surgical treatment of adrenocortical carcinoma (ACC), lymphadenectomy may improve oncologic outcome. However, patterns of metastatic lymphatic spread in... 
CLINICAL-PRACTICE GUIDELINES | SURVIVAL | SURGERY | IMPACT | LAPAROSCOPIC ADRENALECTOMY | EUROPEAN NETWORK | MANAGEMENT | LYMPHADENECTOMY | ONCOLOGY | DISSECTION | RADIOTHERAPY | PROGNOSTIC ROLE
Journal Article
Genetics in Medicine, ISSN 1098-3600, 2018, Volume 20, Issue 12, pp. 1652 - 1662
Purpose: MDH2 (malate dehydrogenase 2) has recently been proposed as a novel potential pheochromocytoma/paraganglioma (PPGL) susceptibility gene, but its role... 
Molecular dynamics | Dominant-negative effect | Variants of unknown significance | MDH2 | pheochromocytoma and paraganglioma | RECURRENT | GENES | GENETICS & HEREDITY | GERMLINE MUTATIONS | PROMOTER
Journal Article
Journal Article
Endocrinology, ISSN 0013-7227, 11/2015, Volume 156, Issue 11, pp. 3895 - 3908
Adrenocortical carcinoma (ACC) is a rare malignancy that harbors a dismal prognosis in advanced stages. Mitotane is approved as an orphan drug for treatment of... 
ADJUVANT MITOTANE | ACTIVATION | UNFOLDED PROTEIN RESPONSE | CHOLESTERYL ESTER | METABOLISM | QUANTIFICATION | MITOCHONDRIA | ENDOCRINOLOGY & METABOLISM | ACAT | CANCER | EXPRESSION | Immunohistochemistry | Transcription Factor CHOP - genetics | Gas Chromatography-Mass Spectrometry | Oligonucleotide Array Sequence Analysis | Apoptosis - drug effects | Humans | Immunoblotting | Endoplasmic Reticulum Stress - genetics | Mitotane - pharmacology | Adrenocortical Carcinoma - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Adrenocortical Carcinoma - metabolism | HEK293 Cells | Sterol O-Acyltransferase - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Adrenal Cortex Neoplasms - metabolism | Cell Survival - drug effects | Antineoplastic Agents, Hormonal - pharmacology | Endoplasmic Reticulum Stress - drug effects | Adrenocortical Carcinoma - genetics | Transcriptome - drug effects | Reverse Transcriptase Polymerase Chain Reaction | Mitotane - therapeutic use | Hep G2 Cells | Adrenal Cortex Neoplasms - drug therapy | Adrenal Cortex Neoplasms - genetics | Disease-Free Survival | Cell Line, Tumor | Sterol O-Acyltransferase - genetics | HeLa Cells | Lipids - analysis | Transcription Factor CHOP - metabolism | Sterol O-Acyltransferase - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 2014, Volume 171, Issue 1, pp. R1 - R11
Journal Article
Pituitary, ISSN 1386-341X, 10/2019, Volume 22, Issue 5, pp. 542 - 551
Clinical trials have demonstrated the favorable efficacy/safety profile of pasireotide in patients with Cushing’s disease (CD). We report interim long-term... 
Medicine & Public Health | Human Physiology | Hypercortisolism | Cushing’s disease | Pituitary | Safety | Pasireotide | Endocrinology | Hyperglycemia | Nervous system diseases | Adrenocorticotropic hormone | Clinical trials | Diarrhea | Nausea | Hydrocortisone | Patients
Journal Article